Goodwill in USD of Cytek Biosciences, Inc. from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Cytek Biosciences, Inc. quarterly Goodwill history and change rate from Q4 2020 to Q3 2025.
  • Cytek Biosciences, Inc. Goodwill for the quarter ending 30 Sep 2025 was $16.7M, a 3.18% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Cytek Biosciences, Inc. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $16.7M +$515K +3.18% 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $16.7M +$524K +3.24% 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 $16.7M +$495K +3.06% 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $16.7M +$480K +2.97% 31 Dec 2024 10-Q 05 Nov 2025
Q3 2024 $16.2M -$274K -1.67% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $16.2M -$2.96M -15.5% 30 Jun 2024 10-Q 06 Aug 2024
Q1 2024 $16.2M -$2.96M -15.5% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 $16.2M +$6.04M +59.5% 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 $16.5M +$6.31M +62.2% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $19.1M +$9M +88.7% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 $19.1M +$9M +88.7% 31 Mar 2023 10-Q 09 May 2023
Q4 2022 $10.1M $0 0% 31 Dec 2022 10-K 13 Mar 2024
Q3 2022 $10.1M +$9.67M +2031% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $10.1M +$9.67M +2031% 30 Jun 2022 10-Q 10 Aug 2022
Q1 2022 $10.1M 31 Mar 2022 10-Q 12 May 2022
Q4 2021 $10.1M +$9.67M +2031% 31 Dec 2021 10-K 01 Mar 2023
Q3 2021 $476K 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $476K 30 Jun 2021 10-Q 03 Sep 2021
Q4 2020 $476K 31 Dec 2020 10-K 17 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.